Talphera (TLPH) Profit After Tax (2010 - 2026)
Talphera's (TLPH) quarterly Profit After Tax came in at -$2.6 million in Q1 2026, up 1.43% year-on-year from -$2.5 million in Q1 2025, and up 33.52% quarter-over-quarter from -$3.8 million in Q4 2025.
Talphera (TLPH) Profit After Tax (2010 - 2026) Analysis & Trends
Talphera's Profit After Tax history runs 17 years deep, the most recent figure standing at -$2.6 million for Q1 2026.
- On a quarterly basis, Profit After Tax rose 1.43% year-over-year to -$2.6 million in Q1 2026; TTM through Mar 2026 was -$14.3 million, a 23.04% decrease from a year earlier, with the FY2025 full-year figure at -$14.4 million, down 10.45% from the prior year.
- Profit After Tax advanced to -$2.6 million in Q1 2026 per TLPH's latest filing, from -$3.8 million in the prior quarter.
- Across five years, Profit After Tax topped out at $70.7 million in Q2 2022 and bottomed at -$17.3 million in Q4 2022.
- The 5-year median for Profit After Tax is -$3.8 million (2025), against an average of -$490411.8.
- Across the five-year window, Profit After Tax surged 817.32% in 2022 and tumbled 136.46% in 2024, its largest moves.
- Year by year, Profit After Tax stood at -$17.3 million in 2022, then soared by 73.9% to -$4.5 million in 2023, then soared by 58.6% to -$1.9 million in 2024, then slumped by 105.61% to -$3.8 million in 2025, then surged by 33.52% to -$2.6 million in 2026.
- Per Business Quant, the three latest TLPH Profit After Tax figures stand at -$2.6 million (Q1 2026), -$3.8 million (Q4 2025), and -$4.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | -2.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.56 Mn |
| Dec 31, 2025 | -3.85 Mn |
| Sep 30, 2025 | -4.44 Mn |
| Jun 30, 2025 | -3.49 Mn |
| Mar 31, 2025 | -2.59 Mn |
| Dec 31, 2024 | -1.87 Mn |
| Sep 30, 2024 | -3.35 Mn |
| Jun 30, 2024 | -3.83 Mn |
| Mar 31, 2024 | -3.95 Mn |
| Dec 31, 2023 | -4.52 Mn |
| Sep 30, 2023 | -1.42 Mn |
| Jun 30, 2023 | -4.37 Mn |
| Mar 31, 2023 | -8.15 Mn |
| Dec 31, 2022 | -17.31 Mn |
| Sep 30, 2022 | -4.64 Mn |
| Jun 30, 2022 | 70.66 Mn |
| Mar 31, 2022 | -8.67 Mn |
| Dec 31, 2021 | -7.92 Mn |
| Sep 30, 2021 | -8.38 Mn |
| Jun 30, 2021 | -9.85 Mn |